Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Atovaquone |
Synonyms | |
Therapy Description |
Mepron (atovaquone) is an anti-malarial drug typically used to treat pneumocystis pneumonia and toxoplasmosis, however, may also have an effect on cancer stem cells via the Warburg effect, potentially resulting in decreased cell proliferation and apoptosis (PMID: 27136895). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Atovaquone | Mepron | Mepron (atovaquone) is an anti-malarial drug typically used to treat pneumocystis pneumonia and toxoplasmosis, however, may also have an effect on cancer stem cells via the Warburg effect, potentially resulting in decreased cell proliferation and apoptosis (PMID: 27136895). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06624371 | Phase I | Atovaquone | Atovaquone Combined with Radiation in Children with Malignant Brain Tumors (AflacBT2303) | Recruiting | USA | 0 |
NCT05998135 | Phase II | Atovaquone | Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer | Recruiting | USA | 0 |
NCT04648033 | Phase I | Atovaquone | Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC (ARCADIAN) | Completed | GBR | 0 |